The Research

Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes

Activation by sAJ2 or addition of monocytes from healthy individuals to patient NK cells increased the secretion of functional IFN-γ by the NK cells and elevated its functional capability to differentiate tumors. Oral ingestion of AJ2 improved the secretion of IFN-γ by patient derived NK cells and resulted in the better functioning of NK cells in cancer patients. In this regard, AJ2 probiotic bacteria may serve to provide a potential adjunct treatment strategy.

Read the paper at the National Library of Medicine

Dr. Anahid Jewett

Dr. Jewett is Professor and Director of tumor immunology laboratory at the UCLA School of Dentistry and Medicine. She has published seminal work in tumor immunology and cancer immunotherapy, in particular NK immunotherapy. She holds many key patents, and has given more than 200 invited lectures nationally and internationally and has published greater than 100 research articles and has served on several NIH study section panels. She has trained more than 150 graduate students and health professionals in her laboratory.

Anahid Jewett, Ph.D, MPH
Professor and Director of Tumor Immunology Laboratory
Division of Oral Biology and Medicine
The Jane and Jerry Weintraub Center for Reconstructive Biotechnology
Jonsson Comprehensive Cancer Center
UCLA School of Dentistry and Medicine
Tel: 310-206-3970
Fax: 310-794-7109
Email address: ajewett@ucla.edu
Address: CHS, B3-088
10833 LeConte Ave
Los Angeles, CA. 90095-1668

Affiliation

Dental and Craniofacial Research Institute
Jonsson Comprehensive Cancer Center (JCCC)
The Jane and Jerry Weintraub Center for Reconstructive Biotechnology
UCLA Tumor Immunology Subgroup

Websites

David Geffen School of Medicine;

http://people.healthsciences.ucla.edu/research/institution/personnel?personnel_id=45339

Jonnson Comprehensive Cancer Center

 https://cancer.ucla.edu/research/find-become-a-member/member-directory?id=129

Frontiers of Tumor Immunity

http://community.frontiersin.org/people/AnahidJewett/116826

Cure Cancer Now Foundation

http://www.curecancernowfoundation.org

Weintraub center for reconstructive biotechnology

https://weintraubcenter.dentistry.ucla.edu/jewett-lab

National Presentations

By Dr. Jewett

  • Anahid Jewett, T. Hoshino, Benjamin Bonavida. Activation of human monocytes tumoricidal activity by OK432 (Abstract #6728 and poster presentation in 1988 FASEB Meeting, Las Vegas, NV)
  • Anahid Jewett, Nabil Hanna, and Benjamin Bonavida. Lack of correlation of macrophage cell mediated cytotoxicity, secreted TNF-mediated cytotoxicity, and secreted TNF detected by RIA (Abstract and poster presentation. January 22, 1989 TNF meeting, Napa Valley, CA.).

Click to see more info

  • Anahid Jewett and Benjamin Bonavida. TNF and IL-1 gene activation in human monocytes treated with Krestin (PSK). (Abstract and poster presentation in Second International Workshop on Cytokines, Dec., 1989. South Carolina).
  • Jewett, A.; Nishonian, P.; and Bonavida B. ADCC against HIV-infected cells by monocytes/Macrophages derived from HIV+ and HIV-individuals. Role in the pathogenesis of AIDS (Abstract and poster presentation in 1989 HIV, Lentiviruses and monocyte/macrophage meeting, San Francisco, CA).
  • Anahid Jewett, B. Bonavida. Antibody dependent cellular cytotoxicity (ADCC) by monocytes from HIV+ and HIV- individuals against HIV-coated target cells. (Abstract and mini symposium oral presentation in 1990 FASEB, New Orleans).
  • Xiao-Hu Gan, A. Jewett, J. Safrit, H. Morimoto, and B. Bonavida. Macrophage mediated tumor cytotoxicity is upregulated by cisplatinum (CDDP). Abstract 1991, FASEB. Atlanta, Georgia (poster presentation).
  • Anahid Jewett, Jonathan Katz, Ronald Mitsuyasu, and Benjamin Bonavida. Activation of NK and monocytes from AIDS patients with the BRM OK432. Abstract 1991, oral presentation, FASEB (Atlanta, Georgia).
  • Laura Lebow, Xiao-Hu Gan, Anahid Jewett, and Benjamin Bonavida. Maturation and differentiation of natural killer (NK) cells: cytokine induction and secretion by Nk subsets. Abstract, FASEB, 1991.
  • Anahid Jewett, Mark Davis, and Benjamin Bonavida. Maturation and differentiation of sorted non-binder free NK cells derived from human peripheral blood. Abstract, oral presentation, FASEB, Anaheim CA 1992.
  • Anahid Jewett, Mark Davis, and Benjamin Bonavida. Modulation of several surface antigens on NK cell subpopulations as a function of maturation and differentiation. Abstract and poster presentation. FASEB, Anaheim CA, 1992.
  • Anahid Jewett and Benjamin Bonavida. Role of endogenous TNF−α secretion in the initiation of IL,2 mediated maturation and differentiation of Free NK cell subset into Killer cells. Abstract and Poster presentation. NK Cell Workshop, St. Petersburg Beach, Florida 1992.
  • Anahid Jewett and Benjamin Bonavida. Interferon-a has a distinct pathway than Il-2 in the maturation and differentiation of Free NK cell subset into Killer cells. Abstract,Poster and Oral presentation. NK cell Workshop, St. Petersburg Beach, Florida,1992.
  • Anahid Jewett and Benjamin Bonavida Failure of dissociated NK conjugate to respond to Il-2 or IFN-a mediated activation. Abstract, Poster and Oral presentation. NK cell Workshop, St. Petersburg Beach, Florida 1992
  • Salahuddin S.Z. Levine S.A. Nakamura S. Kaplan M. Hober D. Jewett A. Xua-Hu G. and B. Bonavida. Cloned tumor cells from AIDs associated lymphoma with interesting in vitro properties. Abstract, American Society of Hematology, Anaheim, CA.1992
  • Anahid Jewett and Benjamin Bonavida. Cells surface antigens or NK cells are associated with functinal inactivation and activation “Leukocyte Differentiation Antigen Workship” Boston. Poster presentation. November 1993
  • Anahid Jewett and Benjamin Bonavida. Selective expression of cell surface antigens on subpopulation of peripheral blood-derived NK subsets. “Leukocyte differentiation Antigen Workshop” Boston. Oral presentation. Nov 1993
  • Demidum A. Salahuddin Z. Lam T. Nakamura S Levine A. Khan R.S. Jewett A. and Bonavida B. Overcoming drug/cytokine resistance f AIDS associated NHL cells following treatment with IFN-g in vitro. AACR. San Francisco
  • Anahid Jewett and Benjamin Bonavida. Target cell mediated inactivation of human peripheral blood NK cells: Split anergy and programmed cell death in a subset of NK cells. FASEB, Anaheim, California. Poster presentation, April, 1994.
  • Demidem, A., Bonavida, B., Salahuddin, Z., Lam, T., Nakamura, S., and Jewett, A. Regulation of cell proliferation and sensitization to drugs of human non-hodgkin B lymphoma cell lines by endogenous cytokines. FASEB, Anaheim, California. Poster presentation, April, 1994.
  • Jewett, A., Giorgi, J., and Bonavida, B. Mechanism of NK inactivation in HIV seropositive individuals. Clinical Immunology meeting, Anaheim, California. Poster presentation, April, 1994.
  • Anahid Jewett and Benjamin Bonavida. Pivotal roles of TNF receptors expression and endogenous TNF- and IFN-g secretion in the IL-2 mediated activation and differentiation of immature NK cells. Fifth International TNF congress. Asilomar, Monterey, California. Oral presentation, May, 1994.
  • Bonavida B., Cavalcanti M., and Jewett A. Apoptosis of NK cells. FASEB, Atlanta Georgia, Poster presentation, April 9-13, 1995
  • Cavalcanti M, Jewett A., X-H Gan, Giorgi J.V. and Bonavida B. Association of phenotypic changes with NK cell inactivation in HIV-infected individuals. FASEB, Atlanta Georgia, Poster presentation, April 9-13, 1995
  • Jewett A, Cavalcanti M, Bonavida B. Inactivation and programmed cell death of NK cells in ADCC mediated by gp120 coated CD4 target cells and anti-HIV serum.FASEB, Atlanta Georgia, Poster presentation, April 9-13, 1995
  • Jewett A., Cavalcanti M., and Bonavida B. Involvement of CD16 ( FcRIII) in target cell activation induced apoptosis in NK cells. Oral presentation, FASEB, New Orleans, June 2-6, 1996
  • Cavalcanti M, Jewett A, and Bonavida B. Failure of IL-2, IL-12, and IL-15 to rescue NK cytolytic function impairment and apoptosis by target cells.FASEB, New Orleans, June 2-6, 1996
  • Jewett A, Bonavida B. Involvement of the adhesion molecules LFA-1 and ICAM-1 in NK-induced apoptosis. Joint meeting of the American Academy of Allergy, Asthma and Immunology. Journal of Allergy and Clinical Immunology, v.99, n.1, 1997.Oral Presentation.
  • Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B. The participation of Fas cytotoxic pathway mediated by natural killer cell in tumor cell dependent Fas-mediated cytotoxicity by peripheral blood-derived NK cells. 88 Annual Meeting of the Proceedings of the American Association for Cancer Research Annual Meeting, v.38,304,1997.
  • Jewett A and Bonavida B. Regulation of anti-CD16 mediated apoptosis in human NK cells by MHC Class I and Killer Inhibitory Receptors(KIR). FASEB, abstract #3512, 1998.
  • Jewett A and Hume W.R. HEMA and TEGDMA trigger human lymphocyte cytokine secretion in vitro. 27th annual American Association for Dental Research, Minneapolis. March 4-7,1998, oral presentation.
  • Jewett A, S. Vaziri and W. R. Hume. Oral blood mononuclear cells resist activation- induced cell death in periodontitis patients.Oral presentation, 30th annual American Association for Dental Research (AADR), March 7-10, 2001, Chicago, IL.
  • A. Jewett, M.Y. Wang and W. R. Hume. Apoptosis-resistant lymphocyte selection is a primary step in 2-hydroxyethylmethacrylate sensitization. Oral presentation, 30th annual American Association for Dental Research (AADR), March 7-10, 2001, Chicago, IL.
  • Le.D. Wang M,Park N. H. and Jewett A .TRAF3, IgFbp6 and P53 as Potential Therapeutic Targets for Oral Cancers. Oral presentation, 30th annual American Association for Dental Research (AADR), March 7-10, 2001, Chicago, IL.
  • Jewett A*, Wang M.and Park M. Mechanisms of Resistance of Oral Tumors to Cytotoxic Immune Effectors. Oral presentation, 30th annual American Association for Dental Research (AADR), March 7-10, 2001, Chicago, IL.
  • ANAHID JEWETT, MEI-YING WANG, MIN SIK PARK. Mechanism of Resistance of Oral Tumors to Matural Killer cell cytotoxicity, Oral presentation, 31th annual American Association for Dental Research (AADR), March, 2002,San Diego, CA.
  • ANAHID JEWETT, LEONARDO CARLOS FERRER BORDADOR, WYATT R HUME. Gene array analysis of patient lymphocytes treated with 2-hydroxyethylmethacrylate. Oral presentation, 31th annual American Association for Dental Research (AADR), March, 2002,San Diego, CA
  • ANAHID JEWETT, HIROMI NAKAMURA, MARJAN RUSHEDI, MIN SIK PARK. Iihibition of nuclear NFkB binding in Hep2 cells rescues NK cells from undergoing cell death by tumor cells. Oral presentation, 31th annual American Association for Dental Research (AADR), March, 2002,San Diego, CA
  • DAVID C. HAN, GEORGE T.-J. HUANG, LOUIS M. LIN, NED WARNER, ANAHID JEWETT, Induced HLA Class II/CD54 cell surface expression and cytokine secretion in oral epithelial cells challenged by selected oral bacteria in vitro, Oral presentation, 31th annual American Association for Dental Research (AADR), March, 2002,San Diego, CA
  • Tandik Evazyan, and Anahid Jewett. Phenotypic and functional characteristics of lymphocytes derived from oral blood of patients with periodontitis and healthy donors: Lack of activation induced cell death distinguishes oral blood mononuclear cells from peripheral blood mononuclear cells. FASEB, 2004
  • A. PARANJPE, W. HUME, and A. JEWETT, Susceptibility of human and mouse cells to HEMA mediated apoptotis, 34th annual American Association for Dental Research (AADR), in Baltimore, MD, March, 2005
  • A. TERUEL, and A. JEWETT, NFkB downmodulation inhibits IL-6 and VEGF secretion in HEp2 tumors, 34th annual American Association for Dental Research (AADR), in Baltimore, MD, March, 2005
  • M. ROMERO, and A. JEWETT, Lack of TNFa production enhances functional activation of immune effectors, 34th annual American Association for Dental Research (AADR), in Baltimore, MD, March, 2005
  • A. PARANJPE, W. HUME, and A. JEWETT, Mechanism of HEMA Mediated Apoptosis in Dental Pulp Stromal Cells, 35th annual American Association for Dental Research (AADR), Orlando, Florida, March 8-11, 2006
  • A. TERUEL and A. JEWETT. Interleukin-6 Secretion Contributes to Immune Inactivation by Oral Tumors. 35th annual American Association for Dental Research (AADR). Orlando, Florida, March 8-11,2006
  • M. ROMERO, and A. JEWETT. Inhibition of TNF-alpha production enhances immunoreactivity against oral cancers. 35th annual American Association for Dental Research (AADR),Orlando, Florida, March 8-11,2006
  • A. JEWETT 1, M. ROMERO 2, A. PARANJPE 1, A. TERUEL 2, and N. CACALANO. Targeting NFkB in oral keratinocytes to generate vaccine against periodontal-pathogens. 35th meeting of AADR. March 21-24, 2007 New Orleans, LA, USA. (oral presentation)
  • N. TSUKIMURA 1, W. YANG 2, N. KOJIMA 1, A. JEWETT 1, and T. OGAWA 1, Co-Culture Effect of Peripheral Blood Mononuclear Cells on Osteoblasts. 36th meeting of AADR. March 21-24, 2007 New Orleans, LA, USA (oral presentation)
  • A. PARANJPE 1, W. HUME 2, and A. JEWETT. Co-modulation of GAPDH and NFkB in HEMA mediated apoptosis. 36th meeting of AADR March 21-24, 2007 New Orleans, LA, USA (oral presentation)
  • N. KOJIMA, M. YAMADA, A. PARANJPE, N. TSUKIMURA, K. KUBO, A. JEWETT, and T. OGAWA, Toxicity and Detoxification of Temporary Filling Resin Material. 36th meeting of AADR March 21-24, 2007 New Orleans, LA, USA (oral presentation)
  • W. YANG, and A. JEWETT. Activation of Smooth Muscle Cells by F. nucleatum during atherogenesis. 36th meeting of AADR. March 21-24, 2007 New Orleans, LA, USA (poster presentation)
  • Involvement of Fc receptor-mediated NK cell inactivation by oral tumors M. JETHWANI, C. TSAI, C. HEAD, and A. JEWETT. 36th meeting of AADR. March 21-24, 2007 New Orleans, LA, USA (oral presentation)
  • M. YAMADA 1, N. KOJIMA 1, A. PARANJPE 1, H. AITA 2, W. ATT 1, T. SUZUKI 1, A. JEWETT 1, and T. OGAWA. Cytotoxicity and Detoxification of Poly-methylmethacrylate Resin to Dental Pulp Cells. 36th meeting of AADR. March 21-24, 2007 New Orleans, LA, USA (oral presentation)
  • Julie Kim, Hong Zhou1, Ana Jewett, and Nicholas A. Cacalano1.Constitutive STAT3 activation in glioblastoma multiforme impairs anti-tumor immunity and production of pro-inflammatory cytokines. AACR, April14-18,2007 (poster presentation).
  • Avina Paranjpe and Anahid Jewett. N-acetyl Cysteine prevents apoptosis and promotes the differentiation of dental pulp stromal cells. Annual session of AAE, 2008, Vancouver-Canada, April 9-12, (Oral presentation)
  • Anahid Jewett , “Novel strategies to enhance function, survival and regeneration of pulp” Annual session of AAE, 2008, Vancouver-Canada, April 9-12, keynote lecture
  • Midori Tachibana and Anahid Jewett. Mechanisms of pulpal infection by pathogenic oral organism Fusobacterium Nucleatum. Annual session of AAE, 2008, Vancouver-Canada, April 9-12, (poster presentation)
  • Anahid Jewett, “Novel strategies to prevent toxicity of dental materials and enhance function, survival and regeneration of pulp.” Annual Academy of Operative Dentistry meeting in Chicago Feb. 24th, 2009. (key note lecture)
  • JEWETT, A. PARANJPE2, E.C. SUNG3, and N. CACALANO1, Strategies to induce maximum regeneration of Dental Pulp Stromal Cells, Miami, Florida,
  • IADR/AADR/CADR 87th General Session and Exhibition (April 1-4,2009) (oral presentation)
  • H. ARASTEH, N. CACALANO, and A. JEWETT, NK Cells Mediated Lysis Of DPSC’s Is Inhibited By Monocytes, Miami, Florida, IADR/AADR/CADR 87th General Session and Exhibition (April 1-4,2009) (oral presentation)
  • DADGAR-YEGANEH, M. TACHIBANA, M. ROMERO-REYES, A. PARANJPE, H. ARASTEH, and A. JEWETT, Effects of Fusobacterium Nucleatum on Human Dental Pulp Stromal Cells, Miami, Florida, IADR/AADR/CADR 87th General Session and Exhibition (April 1-4,2009) (oral presentation)
  • S. SAADAT, N. CACALANO, and A. JEWETT, Monocytes Protect Oral Tumors via NFkB Dependent and Independent Mechanisms, Miami, Florida, IADR/AADR/CADR 87th General Session and Exhibition (April 1-4,2009)(Hutton Competition) (poster presentation)
  • A. BEHEL1, H. ARASTEH1, W. YANG2, D. FARZAM1, N. CACALANO1, and A. JEWETT1, Potent Cytotoxicity of NK’s against MSC is inhibited by monocytes, , Miami, Florida, IADR/AADR/CADR 87th General Session and Exhibition (April 1-4,2009) (poster presentation)
  • D. FARZAM1, H.H. TSENG1, K. VU2, A. DADGAR-YEGANEH1, S. SAADAT1, N. CACALANO1, and A. JEWETT1, Monocyte induced oral tumor cell resistance to NK cell cytotoxicity, , Miami, Florida, IADR/AADR/CADR 87th General Session and Exhibition (April 1-4,2009) (poster presentation)
  • H. GHORBANI-MOGHADDAM, S. SAADAT, D. FARZAM, H.H. TSENG, N. CACALANO, and A. JEWETT, Expression and Function of B7H1 Receptors on Oral Tumors, , Miami, Florida, IADR/AADR/CADR 87th General Session and Exhibition (April 1-4,2009) (poster presentation)
  • H.C.H. TSENG1, D. FARZAM2, A. ARASTEH3, T. SARDARIAN1, N. CACALANO1, and A. JEWETT1, Monocytes and DCs Elevate Survival and Resistance of Oral Tumors, Washington,DC, AADR Annual Meeting (March 3-6, 2010) (oral presentation)
  • A. ARASTEH and H.C.H. TSENG, Strategies to Protect DPSCs and Augment Regeneration of Pulpal Tissue, Washington,DC, AADR Annual Meeting (March 3-6, 2010) (poster presentation)
  • S. KRIFKA1, C. PETZEL1, K. HILLER1, G. SPAGNUOLO2, A. JEWETT3, G. SCHMALZ1, and H. SCHWEIKL1, Resin-monomer modified the expression of antioxidant enzymes, Tampa-Florida, AADR, (March 21-24,2012) (oral presentation)
  • G.M. ORONA1, H. TSENG2, A. ARASTEH3, and A. JEWETT2, Bacterial Lipopolysaccharides Induce Suppression of Natural Killer Cell Function, Tampa-Florida, AADR, (March 21-24,2012)(oral presentation)
  • K. KANAYAMA, SIL PARK, H. HELEN TSENG, ANAHID JEWETT, SHUTING SUN, CHARLES E. MCKENNA, ICHIRO NISHIMURA. Different ONJ susceptibility in B6 and Balb/c mice. AADR; March 22, 2014: Charlotte, North Carolina (poster presentation)
  • P.O. MAUNG, H. TSENG DICK, V.T BUI and A. JEWETT, Combination of chemo-immunotherapy eliminate oral cancer stem cells, AADR/IADR, March 11-14, 2015; Boston, Mass (Oral presentation)
  • Paytsar Topchyan, Kawaljit Kaur, Anna Kozlowska, , Han-Ching Tseng-Dick, and Anahid Jewett; Super NKs prevent tumor CSC growth in BLT humanized mice; AADR/CADR Annual Meeting (March 16-19, 2016) (Los Angeles)(oral presentation)
  • Kawaljit Kaur, Keiichi Kanayama,; Ichiro Nishimura and Anahid Jewett; Bisphosphonate mediated immune cell dysfunction in vivo in oral mucosa; AADR/CADR Annual Meeting (March 16-19, 2016) (Los Angeles)(oral presentation)
  • Diana Wang, Edmund Celis, Avina Paranjpe, Anahid Jewett and Eric Sung; NAC decreases inflammation and pain caused by bleaching agents; AADR/CADR Annual Meeting (March 16-19, 2016) (Los Angeles)(oral presentation)
  • Yujie Sun , Kawaljit Kaur, William McBride, Anahid Jewett, and Ichiro Nishimura; Therapeutic Activation of MDSC Reduced ONJ Symptoms in Mice; AADR/CADR Annual Meeting (March 16-19, 2016) (Los Angeles)(oral presentation)
  • Keiichi Kanayama Ph.D, Kawaljit Kaur, Yujie Sun PhD Student, Anahid Jewett, and Ichiro Nishimura; Humanized Mice as Model System for Osteoclast-derived Oral Immune Plasticity; AADR/CADR Annual Meeting (March 16-19, 2016) (Los Angeles)(oral presentation).
  • Anahid Jewett, Guido Eibl and Kawaljit Kaur. High Fat Diet Risk Factor for Gingival Immunosuppression and Cancer; IADR/AADR; March 22-25; 2017, San Francisco, CA (oral presentation)
  • Kawaljit Kaur, Yujie Sun, Jessica Cook, Anahid Jewett and Ichiro Nishimura; Mechanisms of Bisphosphonate-mediated Immune Dysfunction in BLT Humanized, IADR/AADR; March 22-25; 2017, San Francisco, CA (poster presentation)
  • Anahid Jewett; Super-Charged NK Cells For Cancer Treatment; Clinical application of CAR-T cells; Memorial Sloan Kettering Cancer Center (MSKCC), New York. November 16-17; 2017 (oral presentation).
  • Anahid Jewett; Innate Killer summit 2018; Therapeutic Use of Super-Charged NK Cells Targeting CSCs/Undifferentiated Pancreatic/Oral Tumors in Humanized BLT Mice, and Their Use in Clinical Trials. March 27-29; San Diego, CA (oral presentation).
  • Meng-Wei Ko, Kawaljit Kuar, Anahid Jewett. Mechanisms of CD8+ T cells Expansion by Super-Charged NK cells; UCLA research day presentations; February 20, 2019, UCLA
  • Anahid Jewett; Super-charged NK cells and probiotic bacteria for treatment of pancreatic and oral cancers; Journey from in vitro basic biology to studies in humanized mice and human clinical trials; Innate Killer Summit; 19-21 March 2019,| San Diego
  • Anahid Jewett; Enhanced immunity and increased differentiation of tumor cells within tumor microenvironment by super-charged NK cells; Workshop presentation; Innate Killer Summit; 19-21 March 2019,| San Diego
  • Anahid Jewett; Day 1 opening; History of NK cells, their advantages and challenges in cancer therapy; Innate Killer Summit; 19-21 March 2019,| San Diego
  • Anahid Jewett; Day 2 opening; Advantages and challenges of NK therapy within suppressive tumor microenviornment Innate Killer Summit; 19-21 March 2019,| San Diego
  • Anahid Jewett; Anti-Tumor Effects of Cannabinoids and the Role of the Immune System; past, present and the future; 3rd Annual UCLA Cannabis Research Symposium, May 16th, 2019
  • Anahid Jewett, Natural Killer Cells, Probiotics, and Cannabis. Cannabis Science Conference west. September 4–6, 2019 Portland, Orgeon
  • Anahid Jewett, The many key functions of Natural Killers cells in premalignant and malignant stages of tumorigenesis; when these gatekeepers are gone or defective anarchy ensues; The First International Mini Symposium; Successes and Challenges of NK IMMUNOTHERAPY:BREAKING TOLERANCE TO CANCER
  • RESISTANCE, UCLA, March 20-21, 2020 https://www.1nk-immunotherapyconf.com/
  • Anahid Jewett, Mechanisms Governing the Selection & Expansion of CD8+ T Cells by Super-Charged NK Cells from Human Donors & Humanized Mice, March 24-26 2020 | San Diego, CA, https://innate-killer.com/whats-on/
  • Anahid Jewett, Distinct effects of Cannabinoids on Differentiated vs. Cancer Stem cells; Role in Natural Killer Cell activation. March 24-26 2020 | San Diego, CA, https://innate-killer.com/whats-on/
  • Of 90 presentations 70 were oral presentations. Of the 66 oral presentations 37 was given by A. Jewett and 28 by her Post-doctoral fellows, graduate students (both Master’s and PhD level) and 5 by her collaborators.